Latest & greatest articles for myocardial infarction

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on myocardial infarction or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on myocardial infarction and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for myocardial infarction

41. Exploring the nature of sleep disturbance in individuals post-myocardial infarction

Exploring the nature of sleep disturbance in individuals post-myocardial infarction Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

42. Management of non-ST-elevated myocardial infarction (NSTEMI) in elderly patients above the age of 75: systematic review and meta-analysis of RCTs

Management of non-ST-elevated myocardial infarction (NSTEMI) in elderly patients above the age of 75: systematic review and meta-analysis of RCTs Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

43. Serial point of care troponin (POC) tests to rule out acute myocardial infarction in Emergency department

Serial point of care troponin (POC) tests to rule out acute myocardial infarction in Emergency department Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

44. The clinical efficacy and safety of the Chinese herbal medicine Astragalus (Huangqi) preparation for the treatment of acute myocardial infarction: a systematic review of randomized controlled trials

The clinical efficacy and safety of the Chinese herbal medicine Astragalus (Huangqi) preparation for the treatment of acute myocardial infarction: a systematic review of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

45. Effects of recombinant human brain natriuretic peptide on the cardiac function in patients with acute myocardial infarction after percutaneous coronary intervention: a systematic review and meta-analysis

Effects of recombinant human brain natriuretic peptide on the cardiac function in patients with acute myocardial infarction after percutaneous coronary intervention: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

46. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: a meta-analysis of eighteen randomized controlled trials

High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: a meta-analysis of eighteen randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate

2019 PROSPERO

47. Point of care troponin (POC) tests to rule out acute myocardial infarction in the prehospital environment

Point of care troponin (POC) tests to rule out acute myocardial infarction in the prehospital environment Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

48. An appraisal of evidence-based clinical practice guidelines for the management of ST-elevation myocardial infarction (STEMI) using the AGREE II instrument: a systematic review

An appraisal of evidence-based clinical practice guidelines for the management of ST-elevation myocardial infarction (STEMI) using the AGREE II instrument: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

49. Exosomes as a cell-free therapy for cardiac repair: protocol for a systematic review and meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models.

Exosomes as a cell-free therapy for cardiac repair: protocol for a systematic review and meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

50. Radial versus femoral access in patients with ST-segment elevation myocardial infarction: systematic review and meta-analysis of randomized controlled trials

Radial versus femoral access in patients with ST-segment elevation myocardial infarction: systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

51. Hospital mortality of myocardial infarction in Latin America and the Caribbean: contemporary systematic review and meta-analysis

Hospital mortality of myocardial infarction in Latin America and the Caribbean: contemporary systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

52. Outcomes of patients with silent myocardial infarction versus patients without MI or patients with clinical MI: a review and meta-analysis

Outcomes of patients with silent myocardial infarction versus patients without MI or patients with clinical MI: a review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

53. ECMO in cardiogenic shock due to acute myocardial infarction. A systematic review

ECMO in cardiogenic shock due to acute myocardial infarction. A systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

54. Population attributable fraction of myocardial infarction associated with chronic systemic inflammatory disease in North America and Europe

Population attributable fraction of myocardial infarction associated with chronic systemic inflammatory disease in North America and Europe Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

55. Effects of percutaneous coronary intervention stratified into ST elevation myocardial infarction, acute coronary syndrome, and stable coronary disease: a meta-analysis

Effects of percutaneous coronary intervention stratified into ST elevation myocardial infarction, acute coronary syndrome, and stable coronary disease: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

56. Culprit-only versus multivessel percutaneous coronary intervention in ST-segment elevation myocardial infarction and multivessel coronary disease: meta-analysis of randomized controlled trials

Culprit-only versus multivessel percutaneous coronary intervention in ST-segment elevation myocardial infarction and multivessel coronary disease: meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

57. Therapeutic hypothermia in patients with acute myocardial infarction: a systematic review and meta-analysis of randomized trials

Therapeutic hypothermia in patients with acute myocardial infarction: a systematic review and meta-analysis of randomized trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

58. Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia. (PubMed)

Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia. The Hospital Readmissions Reduction Program (HRRP) has been associated with a reduction in readmission rates for heart failure (HF), acute myocardial infarction (AMI), and pneumonia. It is unclear whether the HRRP has been associated with change in patient mortality.To determine whether the HRRP was associated

2018 JAMA

59. Christmas, national holidays, sport events, and time factors as triggers of acute myocardial infarction: SWEDEHEART observational study 1998-2013. (Full text)

Christmas, national holidays, sport events, and time factors as triggers of acute myocardial infarction: SWEDEHEART observational study 1998-2013. To study circadian rhythm aspects, national holidays, and major sports events as triggers of myocardial infarction.Retrospective observational study using the nationwide coronary care unit registry, SWEDEHEART.Sweden.283 014 cases of myocardial infarction reported to SWEDEHEART between 1998 and 2013. Symptom onset date was documented for all cases (...) , and time to the nearest minute for 88%.Myocardial infarctions with symptom onset on Christmas/New Year, Easter, and Midsummer holiday were identified. Similarly, myocardial infarctions that occurred during a FIFA World Cup, UEFA European Championship, and winter and summer Olympic Games were identified. The two weeks before and after a holiday were set as a control period, and for sports events the control period was set to the same time one year before and after the tournament. Circadian

2018 BMJ PubMed

60. Non-ST-elevation myocardial infarction

Non-ST-elevation myocardial infarction Non-ST-elevation myocardial infarction - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Non-ST-elevation myocardial infarction Last reviewed: February 2019 Last updated: December 2018 Summary Part of the acute coronary syndrome spectrum. Usually caused by a partial or near-complete occlusion of a coronary artery resulting in compromised blood flow to myocardium with subsequent (...) myocardial injury or infarction as demonstrated by elevation in troponin. There are differences in typical presentation between the sexes. Male patients typically present with chest pressure/discomfort lasting at least several minutes, at times accompanied by sweating, dyspnoea, nausea, and/or anxiety. Women present more commonly with middle/upper back pain or dyspnoea and similar associated symptoms. Symptoms are indistinguishable from those of unstable angina. However, non-ST-elevation myocardial

2018 BMJ Best Practice